IBDEI12J ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38798,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,38798,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,38798,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,38799,0)
 ;;=E83.30^^148^1939^46
 ;;^UTILITY(U,$J,358.3,38799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38799,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,38799,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,38799,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,38800,0)
 ;;=E83.51^^148^1939^28
 ;;^UTILITY(U,$J,358.3,38800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38800,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,38800,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,38800,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,38801,0)
 ;;=E83.52^^148^1939^26
 ;;^UTILITY(U,$J,358.3,38801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38801,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,38801,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,38801,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,38802,0)
 ;;=E87.5^^148^1939^27
 ;;^UTILITY(U,$J,358.3,38802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38802,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,38802,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,38802,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,38803,0)
 ;;=E89.2^^148^1939^48
 ;;^UTILITY(U,$J,358.3,38803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38803,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,38803,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,38803,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,38804,0)
 ;;=E89.6^^148^1939^47
 ;;^UTILITY(U,$J,358.3,38804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38804,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,38804,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,38804,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,38805,0)
 ;;=L68.0^^148^1939^25
 ;;^UTILITY(U,$J,358.3,38805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38805,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,38805,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,38805,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,38806,0)
 ;;=M80.00XA^^148^1939^2
 ;;^UTILITY(U,$J,358.3,38806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38806,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,38806,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,38806,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,38807,0)
 ;;=M81.0^^148^1939^3
 ;;^UTILITY(U,$J,358.3,38807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38807,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,38807,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,38807,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,38808,0)
 ;;=M85.80^^148^1939^44
 ;;^UTILITY(U,$J,358.3,38808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38808,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,38808,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,38808,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,38809,0)
 ;;=N62.^^148^1939^24
 ;;^UTILITY(U,$J,358.3,38809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38809,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,38809,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,38809,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,38810,0)
 ;;=E10.43^^148^1939^6
 ;;^UTILITY(U,$J,358.3,38810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38810,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,38810,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,38810,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,38811,0)
 ;;=E10.59^^148^1939^4
 ;;^UTILITY(U,$J,358.3,38811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38811,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,38811,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,38811,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,38812,0)
 ;;=E10.618^^148^1939^5
 ;;^UTILITY(U,$J,358.3,38812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38812,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,38812,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,38812,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,38813,0)
 ;;=E10.621^^148^1939^7
 ;;^UTILITY(U,$J,358.3,38813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38813,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,38813,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,38813,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,38814,0)
 ;;=E10.622^^148^1939^11
 ;;^UTILITY(U,$J,358.3,38814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38814,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,38814,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,38814,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,38815,0)
 ;;=E10.65^^148^1939^10
 ;;^UTILITY(U,$J,358.3,38815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38815,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,38815,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,38815,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,38816,0)
 ;;=E10.39^^148^1939^9
 ;;^UTILITY(U,$J,358.3,38816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38816,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,38816,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,38816,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,38817,0)
 ;;=E66.3^^148^1939^45
 ;;^UTILITY(U,$J,358.3,38817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38817,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,38817,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,38817,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,38818,0)
 ;;=E89.1^^148^1939^49
 ;;^UTILITY(U,$J,358.3,38818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38818,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,38818,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,38818,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,38819,0)
 ;;=H40.9^^148^1940^9
 ;;^UTILITY(U,$J,358.3,38819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38819,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,38819,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,38819,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,38820,0)
 ;;=H26.9^^148^1940^5
 ;;^UTILITY(U,$J,358.3,38820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38820,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,38820,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,38820,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,38821,0)
 ;;=H10.9^^148^1940^8
 ;;^UTILITY(U,$J,358.3,38821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38821,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,38821,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,38821,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,38822,0)
 ;;=H11.32^^148^1940^6
 ;;^UTILITY(U,$J,358.3,38822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38822,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,38822,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,38822,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,38823,0)
 ;;=H11.31^^148^1940^7
 ;;^UTILITY(U,$J,358.3,38823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38823,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,38823,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,38823,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,38824,0)
 ;;=H01.002^^148^1940^3
 ;;^UTILITY(U,$J,358.3,38824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38824,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,38824,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,38824,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,38825,0)
 ;;=H01.004^^148^1940^2
 ;;^UTILITY(U,$J,358.3,38825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38825,1,3,0)
 ;;=3^Blepharitis Unspec,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,38825,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,38825,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,38826,0)
 ;;=H01.005^^148^1940^1
 ;;^UTILITY(U,$J,358.3,38826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38826,1,3,0)
 ;;=3^Blepharitis Unspec,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,38826,1,4,0)
 ;;=4^H01.005
